Sleep Health Enhancement for Middle-Aged Adults
Trial Summary
What is the purpose of this trial?
Despite the strong links between sleep and AD, a sleep health enhancement has yet to be targeted in mid-life adults (45-64 years old) to delay or prevent AD. An intervention aimed at enhancing sleep health is a critical opportunity for primary prevention to potentially delay the onset of AD. The objective of the proposed study is to develop and assess the feasibility, acceptability, and treatment effect of a comprehensive sleep health intervention (SHI) on improving sleep health in mid-life adults
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you regularly use medications to improve sleep more than twice a week.
What data supports the effectiveness of the treatment Sleep Health Enhancement for Middle-Aged Adults?
Is the Sleep Health Enhancement treatment safe for humans?
How is the Sleep Health Enhancement Intervention different from other treatments for sleep issues in middle-aged adults?
Eligibility Criteria
This trial is for mid-life adults aged 45-64 who are interested in improving their sleep health as a way to potentially prevent Alzheimer's disease. The study will develop and test the feasibility of a comprehensive sleep health intervention.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Wait-List Control
Participants in the wait-list group will continue with their usual activities for 4 weeks before starting the sleep health enhancement intervention
Sleep Health Enhancement Intervention
4 weekly visits using Zoom video conferencing consisting of education and strategies to enhance sleep health
Follow-up
Participants are monitored for sleep quality and cognitive performance post-intervention
Treatment Details
Interventions
- Sleep health enhancement intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor